Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooke E Wilson

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
JAMA|May 20, 2024
Study Participants, Future Patients, and Outcomes That Matter in Cancer Clinical TrialsBrooke E Wilson, Elizabeth A Eisenhauer, Christopher M Booth
Cancer|November 2, 2023
Efficacy-effectiveness gaps in oncology: Looking beyond survivalBrooke E Wilson, Timothy P Hanna, Christopher M Booth
BMJ Oncology|June 16, 2025
Surveillance imaging: minimal evidence and forgotten harmsHaydee Verduzco-Aguirre, Christopher M Booth, Brooke E Wilson
The Lancet. Oncology|October 4, 2019
A critique of the fragility indexAlexandra Desnoyers, Michelle B Nadler, Brooke E Wilson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2021
Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology TrialsBrooke E Wilson, Michelle B Nadler, Alexandra Desnoyers, et al.
Journal of the National Cancer Institute|September 26, 2025
"While you are on chemotherapy…": common recommendations that lack evidence and may cause harmBrooke E Wilson, Christopher Jackson, Michelle Tregear, et al.
Cancer Treatment Reviews|March 2, 2021
Fragility index of trials supporting approval of anti-cancer drugs in common solid tumoursAlexandra Desnoyers, Brooke E Wilson, Michelle B Nadler, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2019
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studiesBrooke E Wilson, Bertrand Routy, Adnan Nagrial, et al.
Frontiers in Genetics|April 17, 2023
Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potentialBrooke E Wilson, Qiang Shen, David W Cescon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2024
Surveillance Imaging After Curative-Intent Treatment for Cancer: Benefits, Harms, and EvidenceBrooke E Wilson, Kristin Wright, Rachel Koven, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
JAMA|May 20, 2024
Study Participants, Future Patients, and Outcomes That Matter in Cancer Clinical TrialsBrooke E Wilson, Elizabeth A Eisenhauer, Christopher M Booth
Cancer|November 2, 2023
Efficacy-effectiveness gaps in oncology: Looking beyond survivalBrooke E Wilson, Timothy P Hanna, Christopher M Booth
BMJ Oncology|June 16, 2025
Surveillance imaging: minimal evidence and forgotten harmsHaydee Verduzco-Aguirre, Christopher M Booth, Brooke E Wilson
The Lancet. Oncology|October 4, 2019
A critique of the fragility indexAlexandra Desnoyers, Michelle B Nadler, Brooke E Wilson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2021
Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology TrialsBrooke E Wilson, Michelle B Nadler, Alexandra Desnoyers, et al.
Journal of the National Cancer Institute|September 26, 2025
"While you are on chemotherapy…": common recommendations that lack evidence and may cause harmBrooke E Wilson, Christopher Jackson, Michelle Tregear, et al.
Cancer Treatment Reviews|March 2, 2021
Fragility index of trials supporting approval of anti-cancer drugs in common solid tumoursAlexandra Desnoyers, Brooke E Wilson, Michelle B Nadler, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2019
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studiesBrooke E Wilson, Bertrand Routy, Adnan Nagrial, et al.
Frontiers in Genetics|April 17, 2023
Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potentialBrooke E Wilson, Qiang Shen, David W Cescon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2024
Surveillance Imaging After Curative-Intent Treatment for Cancer: Benefits, Harms, and EvidenceBrooke E Wilson, Kristin Wright, Rachel Koven, et al.
Pageof 7